Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cerami

Showing results (11-20 of 362) with videos related to

Pageof 37
Sort By:
Journal of Internal Medicine|February 16, 2012
The unexpected pathway to the creation of the HbA1c test and the discovery of AGE'sA Cerami
Minerva Medica|October 1, 1974
[A disease which is not always free of sequelae]A Cerami
Journal of Medicinal Chemistry|January 1, 1984
Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analoguesP Ulrich, A Cerami
Journal of Medicinal Chemistry|June 1, 1982
Potential antitrypanosomal agents. 1,N2-Disubstituted 2-amino-5-hydroxy-4-methylnaphtho[1,2-d]thiazolium salts and related compoundsP Ulrich, A Cerami
Novartis Foundation Symposium|March 31, 2001
Pharmaceutical intervention of advanced glycation endproductsA Cerami, P Ulrich
Advances in Immunology|January 1, 1988
The common mediator of shock, cachexia, and tumor necrosisB Beutler, A Cerami
Parasitology Today (Personal Ed.)|November 1, 1987
Cachectin--Tumour necrosis factor: a cytokine that mediates injury initiated by invasive parasitesB Beutler, A Cerami
Annual Review of Biochemistry|January 1, 1988
Tumor necrosis, cachexia, shock, and inflammation: a common mediatorB Beutler, A Cerami
Journal of Internal Medicine|November 20, 2008
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury responseM Brines, A Cerami
Nature|April 17, 1986
Cachectin and tumour necrosis factor as two sides of the same biological coinB Beutler, A Cerami
Pageof 37

Showing results (11-20 of 362) with videos related to

Sort By:
Pageof 37
Journal of Internal Medicine|February 16, 2012
The unexpected pathway to the creation of the HbA1c test and the discovery of AGE'sA Cerami
Minerva Medica|October 1, 1974
[A disease which is not always free of sequelae]A Cerami
Journal of Medicinal Chemistry|January 1, 1984
Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analoguesP Ulrich, A Cerami
Journal of Medicinal Chemistry|June 1, 1982
Potential antitrypanosomal agents. 1,N2-Disubstituted 2-amino-5-hydroxy-4-methylnaphtho[1,2-d]thiazolium salts and related compoundsP Ulrich, A Cerami
Novartis Foundation Symposium|March 31, 2001
Pharmaceutical intervention of advanced glycation endproductsA Cerami, P Ulrich
Advances in Immunology|January 1, 1988
The common mediator of shock, cachexia, and tumor necrosisB Beutler, A Cerami
Parasitology Today (Personal Ed.)|November 1, 1987
Cachectin--Tumour necrosis factor: a cytokine that mediates injury initiated by invasive parasitesB Beutler, A Cerami
Annual Review of Biochemistry|January 1, 1988
Tumor necrosis, cachexia, shock, and inflammation: a common mediatorB Beutler, A Cerami
Journal of Internal Medicine|November 20, 2008
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury responseM Brines, A Cerami
Nature|April 17, 1986
Cachectin and tumour necrosis factor as two sides of the same biological coinB Beutler, A Cerami
Pageof 37